BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 21898680)

  • 1. Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis.
    Duijvestein M; Wildenberg ME; Welling MM; Hennink S; Molendijk I; van Zuylen VL; Bosse T; Vos AC; de Jonge-Muller ES; Roelofs H; van der Weerd L; Verspaget HW; Fibbe WE; te Velde AA; van den Brink GR; Hommes DW
    Stem Cells; 2011 Oct; 29(10):1549-58. PubMed ID: 21898680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
    World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
    Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
    Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis.
    Chen Y; Song Y; Miao H; Xu Y; Lv M; Wang T; Hou Y
    Inflamm Res; 2015 Sep; 64(9):671-81. PubMed ID: 26153869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles Secreted by Mesenchymal Stromal Cells Exert Opposite Effects to Their Cells of Origin in Murine Sodium Dextran Sulfate-Induced Colitis.
    Tolomeo AM; Castagliuolo I; Piccoli M; Grassi M; Magarotto F; De Lazzari G; Malvicini R; Caicci F; Franzin C; Scarpa M; Macchi V; De Caro R; Angriman I; Viola A; Porzionato A; Pozzobon M; Muraca M
    Front Immunol; 2021; 12():627605. PubMed ID: 33927713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase.
    Lim JY; Kim BS; Ryu DB; Kim TW; Park G; Min CK
    Stem Cell Res Ther; 2021 Jan; 12(1):37. PubMed ID: 33413597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L
    Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis.
    Castelo-Branco MT; Soares ID; Lopes DV; Buongusto F; Martinusso CA; do Rosario A; Souza SA; Gutfilen B; Fonseca LM; Elia C; Madi K; Schanaider A; Rossi MI; Souza HS
    PLoS One; 2012; 7(3):e33360. PubMed ID: 22432015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis.
    Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H
    Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ-mediated secretion of tryptophanyl-tRNA synthetases has a role in protection of human umbilical cord blood-derived mesenchymal stem cells against experimental colitis.
    Kang I; Lee BC; Lee JY; Kim JJ; Lee SE; Shin N; Choi SW; Kang KS
    BMB Rep; 2019 May; 52(5):318-323. PubMed ID: 30293546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
    Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
    Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice.
    Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY
    Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice.
    Xu J; Wang X; Chen J; Chen S; Li Z; Liu H; Bai Y; Zhi F
    Theranostics; 2020; 10(26):12204-12222. PubMed ID: 33204338
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis.
    Molendijk I; Barnhoorn MC; de Jonge-Muller ES; Mieremet-Ooms MA; van der Reijden JJ; van der Helm D; Hommes DW; van der Meulen-de Jong AE; Verspaget HW
    J Crohns Colitis; 2016 Aug; 10(8):953-64. PubMed ID: 26896084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway.
    Qiu Y; Guo J; Mao R; Chao K; Chen BL; He Y; Zeng ZR; Zhang SH; Chen MH
    Mucosal Immunol; 2017 May; 10(3):727-742. PubMed ID: 27649928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat.
    Tanaka H; Arimura Y; Yabana T; Goto A; Hosokawa M; Nagaishi K; Yamashita K; Yamamoto H; Sasaki Y; Fujimiya M; Imai K; Shinomura Y
    J Gastroenterol; 2011 Feb; 46(2):143-52. PubMed ID: 20848145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.